Physician profile
Mark A Rolain
NPI 1366481855
$7,966.07
in general payments reported to CMS, 2019-2025
14 companies · $595 in 2025
The $595 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,996 · 2020: $411 · 2021: $659 · 2022: $1,117 · 2023: $1,120 · 2024: $1,068 · 2025: $595.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,783.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,783.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $3,549.74 | 2019-2025 | Clareon, Centurion, Hydrus Microstent |
| Johnson & Johnson Surgical Vision, INC. | $2,633.09 | 2019-2024 | Tecnis Iol, Idesign Rs, Whitestar Signature |
| Carl Zeiss Meditec USA, INC. | $492.74 | 2023-2025 | Forum, Artevo 800, Iolmaster 700 |
| Sight Sciences, INC. | $283.84 | 2022-2024 | Omni Surgical System |
| Rxsight INC | $165.26 | 2025 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Ocular Therapeutix, INC. | $159.92 | 2021-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $129.51 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $119.32 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $116.42 | 2019 | |
| Bausch & Lomb Americas INC. | $115.46 | 2022-2025 | Stellaris, Envista Mx60 Iol |
| Visionix USA, INC | $93.44 | 2022 | |
| New World Medical,INC. | $75.55 | 2023 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Glaxosmithkline, LLC. | $12.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Rolain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.